Impact of vitamins A, B, C, D, and E supplementation on improvement and mortality rate in ICU patients with coronavirus-19: a structured summary of a study protocol for a randomized controlled trial
Study Protocol
[키워드] 1:1
Abnormalities
absence
Ascorbate
assigned
baseline
Biotin
block
BMI
body temperature
Chemotherapy
clinical
clinical trial
clinical trials
Complete
condition
control group
COVID-19
CRP
CT scan
definitive diagnosis
dissemination
Duration
element
eligible patient
ESR
evaluate
exclusion criteria
expected
female patient
Folic acid
Gender
HIV
Hospitalization
Hypothesis
ICU
ICU patient
IL6
Imam
Impact
IMPROVE
include
inclusion criteria
intensive care unit
Intervention
invasive
Iran
kidneys
liver
lung
male
mortality rate
New
nicotinamide
Non-invasive
number
objective
organ
outcome
oxygen saturation
pantothenate
parallel group
participant
participated
Patient
patients
patients with COVID-19
PCR
per day
percentage
phosphate
Placebo
polymerase chain
protocol
pulmonary involvement
randomization
Randomized
Randomized controlled trial
Randomly
receive
registry
renal
researcher
respiratory
Riboflavin
Sample size
severity
significantly
sodium
SpO2
Study protocol
Supplementation
Support
table
Tehran
the patient
thiamine nitrate
TNF-α
Treatment
Two-arm
viral disease
Vitamin
vitamin A
Vitamin B
Vitamin C
Vitamin D
Vitamin E
WBC
website
weight
with COVID-19
[DOI] 10.1186/s13063-020-04547-0 PMC 바로가기 [Article Type] Study Protocol
[DOI] 10.1186/s13063-020-04547-0 PMC 바로가기 [Article Type] Study Protocol